Keyphrases
Tumor-specific
100%
COVID-19
100%
Pancreatic Ductal Adenocarcinoma
100%
Tumor-associated Macrophages
100%
Monocytes
100%
Protective Immunity
100%
CD4 T Cells
100%
Neutralizing Abs
66%
Macrophages
60%
Antitumor
60%
Monocyte Differentiation
40%
Tumor Antigen Presentation
40%
MHC Class II
40%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
33%
Epitope Coverage
33%
Weight Loss
33%
Emerging Variants
33%
Viral Load
33%
Syrian Hamster
33%
Study Support
33%
Effector Mechanisms
33%
Viral
33%
Human Adenovirus Type 5
33%
K18-hACE2 Mice
33%
Receptor-binding Domain
33%
Nucleocapsid (N) Protein
33%
COVID-19 Pandemic
33%
Recall Response
33%
Vaccination
33%
Immune Effectors
33%
Respiratory mucosa
33%
Spike Protein
33%
Specific T Cells
33%
Vaccine-induced Immunity
33%
Fate Mapping
20%
Immunotherapy Resistance
20%
Monocyte-derived Macrophages
20%
Macrophage Subsets
20%
Th1 Cells
20%
Tumor Microenvironment
20%
Single-cell RNA Sequencing (scRNA-seq)
20%
Mapping Approach
20%
CD40
20%
Macrophage Heterogeneity
20%
CD8+ T Cells
20%
In Cancer
20%
Pro-tumor
20%
Tissue-resident Macrophages
20%
Regulatory T (Treg) Cells
20%
Immune Infiltration
20%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Macrophage
100%
T-Helper Cell
100%
Virus Nucleocapsid
100%
Spike
100%
COVID-19
25%
Viral Load
25%
Epitope
25%
Receptor Binding
25%
Human Adenovirus 5
25%
Syrian Hamster
25%
Respiratory Mucosa
25%
T Cell
25%
Cytotoxic T-Cell
22%
Tumor-Associated Macrophage
22%
Major Histocompatibility Complex
22%
Antigen Presentation
22%
Tumor Antigen
22%
Regulatory T Cell
11%
Macrophage Subset
11%
CD4
11%
Th1 Cell
11%
RNA Sequence
11%
Immunocompetent Cell
11%
Immunotherapy
11%
